ENTRY       D03222                      Drug
NAME        Belatacept (USAN/INN);
            Nulojix (TN)
PRODUCT     NULOJIX (E.R. Squibb & Sons)
FORMULA     C3508H5440N922O1096S32
EXACT_MASS  79042.9351
MOL_WEIGHT  79092.329
SEQUENCE    MHVAQPAVVL ASSRGIASFV CEYASPGKYT EVRVTVLRQA DSQVTEVCAA TYMMGNELTF
            LDDSICTGTS SGNQVNLTIQ GLRAMDTGLY ICKVELMYPP PYYEGIGNGT QIYVIDPEPC
            PDSDQEPKSS DKTHTSPPSP APELLGGSSV FLFPPKPKDT LMISRTPEVT CVVVDVSHED
            PEVKFNWYVD GVEVHNAKTK PREEQYNSTY RVVSVLTVLH QDWLNGKEYK CKVSNKALPA
            PIEKTISKAK GQPREPQVYT LPPSRDELTK NQVSLTCLVK GFYPSDIAVE WESNGQPENN
            YKTTPPVLDS DGSFFLYSKL TVDKSRWQQG NVFSCSVMHE ALHNHYTQKS LSLSPGK
            (Disulfide bridge: 21-92, 48-66, 171-231, 277-335, 120-120')
  TYPE      Peptide
REMARK      ATC code: L04AA28
            Product: D03222<US>
EFFICACY    Antirheumatic, Immunosuppressant
  DISEASE   Organ rejection, kidney transplant [DS:H00083]
COMMENT     Fusion protein (extracellular domain of CTLA4 fused to Fc of a human IgG1)
            Prevention of allograft rejection in recipients of solid organ transplants, Prevention of graft-vs.-host disease following bone marrow transplantation, Treatment of autoimmune diseases and conditions such as rheumatoid arthritis
TARGET      CD80 [HSA:941] [KO:K05412]
            CD86 [HSA:942] [KO:K05413]
  PATHWAY   hsa04514(941+942)  Cell adhesion molecules
            hsa04672(941+942)  Intestinal immune network for IgA production
            hsa05330(941+942)  Allograft rejection
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L04 IMMUNOSUPPRESSANTS
               L04A IMMUNOSUPPRESSANTS
                L04AA Selective immunosuppressants
                 L04AA28 Belatacept
                  D03222  Belatacept (USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Immunological Agents
              Immunological Agents, Other
               Selective T-cell costimulation modulators
                Belatacept
                 D03222  Belatacept (USAN/INN)
            Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                CD80
                 D03222  Belatacept (USAN/INN) &lt;US&gt;
                CD86
                 D03222  Belatacept (USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D03222
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D03222
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D03222
DBLINKS     CAS: 706808-37-9
            PubChem: 17397375
///
